Inside EU Health Inside EU Health: AZ warns Germany; fair pricing savings €27 B; safe heart screening AstraZeneca warns German reforms could push pharma launches and investment out of Europe; fair pricing model highlights €27 billion of potential savings in Europe; Commission launches consultation on screening for cardiovascular diseases
AstraZeneca AstraZeneca warns German reforms could push pharma launches and investment out of Europe AstraZeneca CEO warns that pharma may avoid launching new medicines in Europe’s largest market
